February 02, 2026
IBSA UK launches non-hormonal injectable for menopausal vulvovaginal symptoms
A next-generation hyaluronic acid treatment designed to improve sexual and genital symptoms of GSM
Watford, UK. February 2nd 2026 - IBSA UK, the UK subsidiary of Swiss pharmaceutical company IBSA, ...











